IP Verse

Human Anti-Il-23 Antibodies, Compositions, Method And Uses

Patent No. EP3219328 (titled "Human Anti-Il-23 Antibodies, Compositions, Method And Uses") was filed by Janssen Biotech on Dec 28, 2006. The application was issued on Jun 17, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABBVIEMar 17, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORF
ABBVIEMar 17, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF
BOEHRINGER INGELHEIMMar 17, 2021HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3219328

JANSSEN BIOTECH
Application Number
EP17156111A
Filing Date
Dec 28, 2006
Status
Revoked
Mar 19, 2021
Publication Date
Jun 17, 2020
External Links
Slate, Register , Google Patents